Balaxi Pharmaceuticals Ltd (BALAXI) Shareholding Pattern - Promoter, FII, DII & Public Holdings
As of Jun 2026, promoters held 65.99% of Balaxi Pharmaceuticals Ltd, FIIs 0%, DIIs 2.56%, government - and the public 31.45%, across 14,682 shareholders.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% |
| FIIs | 16.48% | 16.48% | 16.02% | 8.87% | 3.5% | 1.74% | 0% | 0% |
| DIIs | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 2.56% | 2.56% |
| Public | 17.5% | 17.5% | 17.96% | 25.12% | 30.49% | 32.24% | 31.45% | 31.45% |
| No. of Shareholders | 7,863 | 8,529 | 9,994 | 13,737 | 14,620 | 15,085 | 15,176 | 14,682 |